OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension
Hui Zhang, Angelo D’Alessandro, Min Li, et al.
Vascular Pharmacology (2023) Vol. 149, pp. 107157-107157
Open Access | Times Cited: 8
Hui Zhang, Angelo D’Alessandro, Min Li, et al.
Vascular Pharmacology (2023) Vol. 149, pp. 107157-107157
Open Access | Times Cited: 8
Showing 8 citing articles:
Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms
Hui Zhang, Min Li, Cheng‐Jun Hu, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 914-914
Open Access | Times Cited: 11
Hui Zhang, Min Li, Cheng‐Jun Hu, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 914-914
Open Access | Times Cited: 11
Inosine from purine metabolism enhances fracture healing by coupling fibrinolysis and angiogenesis of type H vessels
Guan-Lin Lee, Chih-Chien Hu, Meifeng Chen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167818-167818
Closed Access
Guan-Lin Lee, Chih-Chien Hu, Meifeng Chen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167818-167818
Closed Access
Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension
A. Dushani C. U. Ranasinghe, T. M. Parinda B. Tennakoon, Margaret A. Schwarz
(2024)
Open Access | Times Cited: 2
A. Dushani C. U. Ranasinghe, T. M. Parinda B. Tennakoon, Margaret A. Schwarz
(2024)
Open Access | Times Cited: 2
Exploring the pathogenesis of pulmonary vascular disease
Chidinma Ejikeme, Zeenat Safdar
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Chidinma Ejikeme, Zeenat Safdar
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Metabolomics in Pulmonary Hypertension—A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology
Pier Paolo Bassareo, Michele D’Alto
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13227-13227
Open Access | Times Cited: 4
Pier Paolo Bassareo, Michele D’Alto
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13227-13227
Open Access | Times Cited: 4
Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension
A. Dushani C. U. Ranasinghe, T. M. Parinda B. Tennakoon, Margaret A. Schwarz
Cells (2024) Vol. 13, Iss. 3, pp. 244-244
Open Access | Times Cited: 1
A. Dushani C. U. Ranasinghe, T. M. Parinda B. Tennakoon, Margaret A. Schwarz
Cells (2024) Vol. 13, Iss. 3, pp. 244-244
Open Access | Times Cited: 1
Understanding pulmonary hypertension: the need for an integrative metabolomics and transcriptomics approach
Priyanka Choudhury, Sanjukta Dasgupta, Parthasarathi Bhattacharyya, et al.
Molecular Omics (2024) Vol. 20, Iss. 6, pp. 366-389
Closed Access
Priyanka Choudhury, Sanjukta Dasgupta, Parthasarathi Bhattacharyya, et al.
Molecular Omics (2024) Vol. 20, Iss. 6, pp. 366-389
Closed Access
Disease mechanisms and therapeutic targets in pulmonary hypertension: Key insights from the special issue of vascular pharmacology on pulmonary hypertension
Beata Wójciak‐Stothard, Sachin A. Gupte, Eduardo Bossone
Vascular Pharmacology (2024) Vol. 156, pp. 107415-107415
Closed Access
Beata Wójciak‐Stothard, Sachin A. Gupte, Eduardo Bossone
Vascular Pharmacology (2024) Vol. 156, pp. 107415-107415
Closed Access
